Clik here to view.
欧州初、ADPKD（常染色体優性多発性のう胞腎）治療薬として 欧州医薬品委員会が「トルバプタン」の承認勧告
東京 （ビジネスワイヤ） — 大塚製薬株式会社（本社：東京都、代表取締役社長：樋口達夫、以下「大塚製薬」）は、「トルバプタン」（海外商標「JINARC®」＜ジンアーク＞）のADPKDの適応に対して、欧州医薬品庁（EMA）の医薬品委員会（CHMP）から承認勧告（positive opinion）が得られたので、お知らせします。...
View ArticleClik here to view.
CHMP RECOMMENDS JINARC® (TOLVAPTAN) FOR APPROVAL IN EU: THE FIRST...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended JINARC® (tolvaptan) for...
View ArticleClik here to view.
「大動脈血管内治療のためのゴア・グローバルレジストリー」の登録患者が2500人を超える
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は、Gore Global Registry for Endovascular Aortic...
View ArticleClik here to view.
东芝推出面向物联网解决方案的ApP Lite(TM)产品族最新产品
东京 (美国商业资讯)–东芝公司(TOKYO:6502)今日宣布推出面向可穿戴设备的“TZ1031MBG”和“TZ1011MBG”应用处理器，作为其ApP Lite™产品族TZ1000系列的最新成员，用于为物联网(IoT)提供解决方案。 Toshiba: new application processor “TZ1011MBG” for wearable devices (Photo:...
View ArticleClik here to view.
TOMI™ Environmental Solutions, Inc. Announces Expansion into the Philippines...
BEVERLY HILLS, Calif. TOMI™ Environmental Solutions, Inc. (“TOMI™” or “the “Company”) (OTCQB: TOMZ), a global bacteria and infectious disease control company, announced today that it has entered...
View ArticleClik here to view.
昆泰任命Elgar Peerschke为咨询服务总裁
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰(Quintiles)今天宣布任命Elgar Peerschke为咨询服务(Advisory Services)总裁。在这一职位上，Peerschke将负责领导昆泰的咨询服务组织及其相关服务的持续开发和交付。 新任命的昆泰咨询服务总裁Elgar Peerschke（照片：美国商业资讯） 加入昆泰前，Elgar任职Bain &...
View ArticleClik here to view.
New Partnership with Meyra Extends Aesynt’s IV Robotics Footprint to the...
CRANBERRY TOWNSHIP, Pa. Aesynt, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, today announced a new strategic partnership with Meyra to market...
View ArticleClik here to view.
NDS Surgical Imaging Announces New 27” Radiance® Ultra, a Revolutionary...
SAN JOSE, Calif. NDS Surgical Imaging (NDSsi) today announced the release of its highly anticipated 27” Radiance® Ultra, a next-generation surgical visualization platform boasting the brightest LED...
View ArticleClik here to view.
Melior Pharmaceuticals Initiates Phase 2 Study with MLR-1023 for Type 2 Diabetes
EXTON, Pa. Melior Pharmaceuticals I, Inc. announced today that it has randomized the first patient into treatment arms of a Phase 2 study aimed at evaluating the efficacy of MLR-1023 towards Type 2...
View ArticleClik here to view.
ResolutionMD Receives Class II Certification for Web and Mobile Diagnosis in...
CALGARY, Alberta Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today that ResolutionMD® medical imaging software has...
View ArticleClik here to view.
昆泰第三次荣获IDG旗下《CSO》杂志评选的技术安全奖
北卡罗来纳三角研究园 (美国商业资讯)–昆泰(Quintiles)今日宣布，公司已获选进入IDG旗下《CSO》杂志2015 CSO50名单，以表彰昆泰用于管理Windows XP安全挑战的风险消减策略。 《CSO》杂志赞扬了昆泰团队创新的深度防御模式，该模式将基于Windows XP的关键业务应用的安全风险降到了最低水平，从而在交付安全和分段式平台的同时保护公司关键资产。...
View ArticleClik here to view.
OKI to Present Four DICOM Color Printers at ECR 2015
TOKYO OKI Data Corporation, an OKI Group company specializing in the printer business, today announced presentation of four unique Digital Imaging and Communications in Medicine (DICOM) printers...
View ArticleClik here to view.
Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep® in...
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT:ALNOV), an international specialist in cancer and infectious disease diagnostics, and Leica Biosystems, a leading supplier to the pathology market,...
View ArticleClik here to view.
Acucela to Hold 2015 Annual Meeting of Shareholders on June 8, 2015
SEATTLE Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of...
View ArticleClik here to view.
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of...
TOKYO & KENILWORTH, N.J. Eisai Co., Ltd. and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, through a subsidiary, announced today a clinical trial collaboration to evaluate the...
View ArticleClik here to view.
Clik here to view.
ViroMed Co., Ltd. dba VM BioPharma: A Phase II Study Done at Northwestern...
ATLANTA & SEOUL, South Korea Northwestern Memorial Hospital (Northwestern University‘s Feinberg School of Medicine) announced the results from a new phase II clinical study published in the...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
R-Tech Ueno: The End of a Phase 3 Clinical Study and Preliminary Findings...
TOKYO R-Tech Ueno (JASDAQ: 4573) announced today the end of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the...
View Article